Ellen P.S. Man

1.9k total citations
24 papers, 1.3k citations indexed

About

Ellen P.S. Man is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ellen P.S. Man has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Genetics. Recurrent topics in Ellen P.S. Man's work include Epigenetics and DNA Methylation (6 papers), FOXO transcription factor regulation (6 papers) and Genetic factors in colorectal cancer (4 papers). Ellen P.S. Man is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), FOXO transcription factor regulation (6 papers) and Genetic factors in colorectal cancer (4 papers). Ellen P.S. Man collaborates with scholars based in Hong Kong, United Kingdom and China. Ellen P.S. Man's co-authors include US Khoo, Ka‐Fai To, Wai K. Leung, Joseph J.�Y. Sung, Eric W.‐F. Lam, Chun Gong, Ana Gomes, Pasarat Khongkow, Michael W.Y. Chan and René H. Medema and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Clinical Cancer Research.

In The Last Decade

Ellen P.S. Man

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen P.S. Man Hong Kong 18 967 407 277 275 144 24 1.3k
Timothy G. Whitsett United States 18 527 0.5× 247 0.6× 266 1.0× 113 0.4× 239 1.7× 35 996
Yongping Cui China 20 640 0.7× 235 0.6× 191 0.7× 61 0.2× 89 0.6× 42 891
Lin Fu China 20 653 0.7× 211 0.5× 274 1.0× 102 0.4× 87 0.6× 34 956
Do-Sun Byun United States 11 1.3k 1.3× 614 1.5× 229 0.8× 189 0.7× 242 1.7× 11 1.7k
Masamitsu Onda Japan 21 730 0.8× 341 0.8× 186 0.7× 137 0.5× 71 0.5× 43 1.2k
Yi-Ji Liao China 15 859 0.9× 237 0.6× 506 1.8× 93 0.3× 175 1.2× 20 1.3k
Duc‐Hiep Bach South Korea 16 810 0.8× 303 0.7× 494 1.8× 83 0.3× 140 1.0× 21 1.2k
Leah M. Cook United States 17 496 0.5× 355 0.9× 190 0.7× 74 0.3× 156 1.1× 35 1.0k
Yiji Liao China 19 1.2k 1.3× 285 0.7× 699 2.5× 110 0.4× 122 0.8× 28 1.6k
Renan Jin China 17 703 0.7× 274 0.7× 463 1.7× 133 0.5× 195 1.4× 34 1.2k

Countries citing papers authored by Ellen P.S. Man

Since Specialization
Citations

This map shows the geographic impact of Ellen P.S. Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen P.S. Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen P.S. Man more than expected).

Fields of papers citing papers by Ellen P.S. Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen P.S. Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen P.S. Man. The network helps show where Ellen P.S. Man may publish in the future.

Co-authorship network of co-authors of Ellen P.S. Man

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen P.S. Man. A scholar is included among the top collaborators of Ellen P.S. Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen P.S. Man. Ellen P.S. Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsoi, Ho, Ellen P.S. Man, Ka Man Cheung, et al.. (2025). Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer. Journal of Translational Medicine. 23(1). 860–860.
2.
Tsoi, Ho, et al.. (2023). SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. Cancers. 15(8). 2271–2271. 1 indexed citations
3.
Tsoi, Ho, et al.. (2022). Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer. International Journal of Molecular Sciences. 23(20). 12290–12290. 2 indexed citations
4.
5.
6.
Gandhi, T. K. B., Ellen P.S. Man, John G. Clohessy, et al.. (2020). Targeting microtubule sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors. Theranostics. 10(6). 2727–2743. 7 indexed citations
7.
Gong, Chun, Ellen P.S. Man, Ho Tsoi, et al.. (2018). BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer. Clinical Cancer Research. 24(15). 3681–3691. 19 indexed citations
8.
An, Liwei, Yiyang Jiang, Ellen P.S. Man, et al.. (2017). Dual-utility NLS drives RNF169-dependent DNA damage responses. Proceedings of the National Academy of Sciences. 114(14). E2872–E2881. 53 indexed citations
9.
Kongsema, Mesayamas, Stefania Zona, Ellen P.S. Man, et al.. (2016). RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment. Oncogenesis. 5(8). e252–e252. 31 indexed citations
10.
Gong, Chun, Ana Gomes, Ellen P.S. Man, et al.. (2016). BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer. Oncogenesis. 5(4). e214–e214. 28 indexed citations
11.
Kongsema, Mesayamas, Stefania Zona, Chun Gong, et al.. (2015). OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene. 35(11). 1433–1444. 122 indexed citations
12.
Moraes, Gabriela Nestal de, Pasarat Khongkow, Chun Gong, et al.. (2015). Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer. Oncogenesis. 4(9). e167–e167. 35 indexed citations
13.
Khongkow, Pasarat, Ana Gomes, Chun Gong, et al.. (2015). Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene. 35(8). 990–1002. 176 indexed citations
14.
Khongkow, Pasarat, Mattaka Khongkow, Chun Gong, et al.. (2013). FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene. 33(32). 4144–4155. 107 indexed citations
15.
Khongkow, Mattaka, Yolanda Olmos, Chun Gong, et al.. (2013). SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis. 34(7). 1476–1486. 129 indexed citations
16.
Cheng, Yuen Yee, Jun Yu, Ellen P.S. Man, et al.. (2007). Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. British Journal of Cancer. 97(7). 895–901. 109 indexed citations
17.
Leung, Wai K., Ka‐Fai To, Ellen P.S. Man, et al.. (2007). Detection of Hypermethylated DNA or Cyclooxygenase-2 Messenger RNA in Fecal Samples of Patients With Colorectal Cancer or Polyps. The American Journal of Gastroenterology. 102(5). 1070–1076. 91 indexed citations
18.
Leung, Wai K., Ellen P.S. Man, Jun Yu, et al.. (2006). Effects of Helicobacter pylori Eradication on Methylation Status of E-Cadherin Gene in Noncancerous Stomach. Clinical Cancer Research. 12(10). 3216–3221. 103 indexed citations
19.
Leung, Wai K., Ka‐Fai To, Ellen P.S. Man, et al.. (2005). Quantitative Detection of Promoter Hypermethylation in Multiple Genes in the Serum of Patients with Colorectal Cancer. The American Journal of Gastroenterology. 100(10). 2274–2279. 123 indexed citations
20.
Bai, Alfa, Joanna H. Tong, Ka‐Fai To, et al.. (2004). Promoter hypermethylation of tumor‐related genes in the progression of colorectal neoplasia. International Journal of Cancer. 112(5). 846–853. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy G. Whitsett Breakdown of academic impact, for papers by Yongping Cui Breakdown of academic impact, for papers by Lin Fu Breakdown of academic impact, for papers by Do-Sun Byun Breakdown of academic impact, for papers by Masamitsu Onda Breakdown of academic impact, for papers by Yi-Ji Liao Breakdown of academic impact, for papers by Duc‐Hiep Bach Breakdown of academic impact, for papers by Leah M. Cook Breakdown of academic impact, for papers by Yiji Liao Breakdown of academic impact, for papers by Renan Jin
Rankless by CCL
2026